Physiological Effects of Drugs Recruiting Phase 4 Trials for Progesterone (DB00396)

IndicationStatusPhase
DBCOND0033861 (Physiological Effects of Drugs)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03677336Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSITreatment